Atlas Trials

A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections

Clinical trial NCT06828848 · RECRUITING

Trial details

NCT number
NCT06828848
Sponsor
Menarini Group
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gram Negative Infections
Start date
2025-02-18
Primary completion
2026-07-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.